Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma

BACKGROUND: Downregulation of Aldolase B (ALDOB) has been reported in hepatocellular carcinoma. However, its clinical significance and its role in pathogenesis of HCC remain largely unknown. METHODS: We analyzed the expression of ALDOB and its clinical features in a large cohort of 313 HCC patients...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Cancer
Egile Nagusiak: Tao, Qi-fei, Yuan, Sheng-xian, Yang, Fu, Yang, Sen, Yang, Yuan, Yuan, Ji-hang, Wang, Zhen-guang, Xu, Qing-guo, Lin, Kong-ying, Cai, Jie, Yu, Jian, Huang, Wei-long, Teng, Xiao-lei, Zhou, Chuan-chuan, Wang, Fang, Sun, Shu-han, Zhou, Wei-ping
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4574028/
https://ncbi.nlm.nih.gov/pubmed/26376879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-015-0437-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak